Jim Tananbaum is the founder and Chief Executive Officer of Foresite Capital. This is a dedicated private equity healthcare firm that specializes in finding upcoming healthcare leaders and helping them to grow by offering information, capital, and networks.
Currently, their largest investment is in Intarcia, a type II diabetes implant that assists patients to lose weight and control their diabetes. Jim Tananbaum believes that the products from Intarcia can have a big effect on Diabetes bearing in mind that diabetes affects more that 350 million people worldwide. The product will launch towards the end of 2017 in the U.S. Aeri Pharmaceuticals is another company Foresite has invested in. Their aim is to bring a glaucoma treatment.
Before forming Foresite, Jim Tananbaum had co-sponsored various companies that have become great healthcare franchises. Immediately after school, Jim was a co-founder and CEO at Geltex Pharmaceuticals. The company was purchased by Genzyme/Sanofi later on. Seven years later, Theravance was born, and it brought GSK to the market, a company responsible for Emphysema and asthma drugs. Jim was also a co-funding stakeholder of HealtheonWebMD, Jazz Pharmaceuticals, and Amerigroup.
During an interview with IdeaMensch, Jim said that the idea for forming Foresite came from the over 25 years’ experience he got as a health care entrepreneur and being an investment strategist. Most of his key success factors lie in the science behind the innovations as well as the team that makes everything a reality.
Jim brings his ideas into life via capital and engaging the most persistent, smartest and effective thought out leaders in healthcare. He said that his business is to give such individuals the means to make vital scientific discoveries that can make a great impact on healthcare.
When asked about the habit that makes him productive, Jim said that his love for learning drives him to find the most ideal and brightest solutions that science can offer. This passion, as well as his unwavering commitment and persistence, allow him to continue expanding his firm and their innovative portfolio.
You can visit his About.me
See more: https://ideamensch.com/jim-tananbaum/